No.

Publication Date

Citing Article

1

2024

Chun Ye, Xiao Liu, Zilun Liu, Chuxuan Pan, Xiaowei Zhang, Zhanyi Zhao, Haitao Sun. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance, Cancer Biology & Therapy. 2024; 25: 2306676.  https://doi.org/10.1080/15384047.2024.2306676

2

2024

Nicola Normanno, Vincenza Caridi, Matteo Fassan, Antonio Avallone, Fortunato Ciardiello, Carmine Pinto. Resistance to immune checkpoint inhibitors in colorectal cancer with deficient mismatch repair/microsatellite instability: misdiagnosis, pseudoprogression and/or tumor heterogeneity?, Exploration of Targeted Anti-tumor Therapy. 2024; 5: 495.  https://doi.org/10.37349/etat.2024.00231

3

2025

Jiajia Zhang, Jingyao Lian, Ningning Li, YueYing, Gang Wu. Multifaceted role of myeloid-derived suppressor cells in colorectal cancer, International Immunopharmacology. 2025; 163: 115274115274.  https://doi.org/10.1016/j.intimp.2025.115274

4

2026

Yan Xu, Qing Cheng, Huilan Yang. Peripheral blood immune cell subsets predict postoperative recurrence in colorectal cancer: a flow cytometry-based retrospective study, Frontiers in Oncology. 2026; 16: 1846793.  https://doi.org/10.3389/fonc.2026.1846793

5

2024

Brett Bell, Kevin Flores-Lovon, Luis A. Cueva-Chicaña, Rodney Macedo. 2024; 388: 20.  https://doi.org/10.1016/bs.ircmb.2024.02.003

6

2024

丽葶 黄, The Role of MDSCs in Digestive System Tumors and Research Progress in Targeted Therapy, Advances in Clinical Medicine. 2024; 14: 925.  https://doi.org/10.12677/acm.2024.1492548

7

2026

Qamar Abuhassan, Ali M Atoom, M.M. Rekha, Jaya Bhanu Kanwar, M. Bavanilatha, Vimal Arora, Aashna Sinha, Alisher Khazratov. Immunological functions of Th17 Cells in colon cancer: From pathogenic mechanisms to emerging treatments, Human Immunology. 2026; 87: 111703111703.  https://doi.org/10.1016/j.humimm.2026.111703

8

2025

唐毅 叶, The Influence of the Colorectal Cancer Immune Microenvironment on Resistance to Cetuximab: Mechanisms and Potential Therapeutic Strategies, Advances in Clinical Medicine. 2025; 15: 2612.  https://doi.org/10.12677/acm.2025.15123695

9

2024

Ye Gu, Qiang Liu, Qiaoxian He, Qiangsheng Wu, Lingyun Li, Dongchao Xu, Liyun Zheng, Lu Xie, Sile Cheng, Hongzhang Shen, Yifeng Zhou, Jianfeng Yang, Hangbin Jin, Xiaofeng Zhang. LC3-dependent extracellular vesicles promote M-MDSC accumulation and immunosuppression in colorectal cancer, iScience. 2024; 27: 109272109272.  https://doi.org/10.1016/j.isci.2024.109272

10

2025

Qingzhe Wang, Min Yu, Shuang Zhang. The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies, Frontiers in Immunology. 2025; 15: 1440830.  https://doi.org/10.3389/fimmu.2024.1440830

11

2025

David L. Drum, Anika G. Jallorina, Leo S. Wan, Victor T. Chang, Mary F. Lee‐Wong. Non‐Genetic Biomarkers in Merkel Cell Carcinoma: Prognostic Implications and Predictive Utility for Response to Anti‐PD‐(L)1 Immune Checkpoint Inhibitors, Experimental Dermatology. 2025; 34: e70030.  https://doi.org/10.1111/exd.70030

12

2026

Clara Salva de Torres, Evelyn Elias, Caterina Vaghi, Nadia Saoudi González, Ariadna García, Adriana Alcaraz, Marta Rodríguez-Castells, Iosune Baraibar, Javier Ros, Francesc Salvà, Josep Tabernero, Elena Élez, Enrique Sanz-Garcia. Exploring resistance to immune checkpoints inhibitors in mismatch repair-deficient or microsatellite-instable colorectal cancer, Cancer Treatment Reviews. 2026; 143: 103089103089.  https://doi.org/10.1016/j.ctrv.2026.103089

13

2026

Mahasin Hamid, Alia M.A. Siddig, Ruaa Suliman, Anwaar Saeed, Ali Mussa, Mohammad A.I. Al-Hatamleh. Targeting colorectal cancer stem-like cells: Overcoming therapeutic resistance and reprogramming the immunosuppressive niche, Cancer Letters. 2026; 656: 218665218665.  https://doi.org/10.1016/j.canlet.2026.218665

14

2026

Rajdeep Roy, Anusree Haldar, Pritam Kumar Das, Nabendu Biswas. Post-treatment tumor immune microenvironment and the dual role of myeloid-derived suppressor cells (MDSCs) in cancer progression and therapeutic resistance, Critical Reviews in Oncology/Hematology. 2026; 221: 105148105148.  https://doi.org/10.1016/j.critrevonc.2026.105148